Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (326)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Vopratelimab	Costimulatory / Bispecific Agent	Solid Tumour
Molecule Vopratelimab Therapeutic Category Immunotherapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Costimulatory / Bispecific Agent
Utomilumab	Costimulatory / Bispecific Agent	Solid Tumour
Molecule Utomilumab Therapeutic Category Immunotherapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Costimulatory / Bispecific Agent
Urelumab	Costimulatory / Bispecific Agent	Solid Tumour
Molecule Urelumab Therapeutic Category Immunotherapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Costimulatory / Bispecific Agent
INCAGN1876 (GITR)	Costimulatory / Bispecific Agent	Solid Tumour
Molecule INCAGN1876 (GITR) Therapeutic Category Immunotherapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Costimulatory / Bispecific Agent
MEDI1873 (GITR)	Costimulatory / Bispecific Agent	Solid Tumour
Molecule MEDI1873 (GITR) Therapeutic Category Immunotherapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Costimulatory / Bispecific Agent
BMS-986156 (GITR)	Costimulatory / Bispecific Agent	Solid Tumour
Molecule BMS-986156 (GITR) Therapeutic Category Immunotherapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Costimulatory / Bispecific Agent
Rilotumumab	Costimulatory / Bispecific Agent	Solid Tumour
Molecule Rilotumumab Therapeutic Category Immunotherapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Costimulatory / Bispecific Agent
Napabucasin	Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase)	Solid Tumour
Molecule Napabucasin Therapeutic Category Targeted Therapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase)
Simtuzumab	Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase)	Solid Tumour
Molecule Simtuzumab Therapeutic Category Targeted Therapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase)
Devimistat	Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase)	Solid Tumour
Molecule Devimistat Therapeutic Category Targeted Therapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase)
IACS-010759	Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase)	Solid Tumour
Molecule IACS-010759 Therapeutic Category Targeted Therapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase)
Telaglenastat	Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase)	Solid Tumour
Molecule Telaglenastat Therapeutic Category Targeted Therapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase)

Vopratelimab Immunotherapy (Investigational)
Therapeutic Category Immunotherapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Costimulatory / Bispecific Agent
Utomilumab Immunotherapy (Investigational)
Therapeutic Category Immunotherapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Costimulatory / Bispecific Agent
Urelumab Immunotherapy (Investigational)
Therapeutic Category Immunotherapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Costimulatory / Bispecific Agent
INCAGN1876 (GITR) Immunotherapy (Investigational)
Therapeutic Category Immunotherapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Costimulatory / Bispecific Agent
MEDI1873 (GITR) Immunotherapy (Investigational)
Therapeutic Category Immunotherapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Costimulatory / Bispecific Agent
BMS-986156 (GITR) Immunotherapy (Investigational)
Therapeutic Category Immunotherapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Costimulatory / Bispecific Agent
Rilotumumab Immunotherapy (Investigational)
Therapeutic Category Immunotherapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Costimulatory / Bispecific Agent
Napabucasin Targeted Therapy (Investigational)
Therapeutic Category Targeted Therapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase)
Simtuzumab Targeted Therapy (Investigational)
Therapeutic Category Targeted Therapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase)
Devimistat Targeted Therapy (Investigational)
Therapeutic Category Targeted Therapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase)
IACS-010759 Targeted Therapy (Investigational)
Therapeutic Category Targeted Therapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase)
Telaglenastat Targeted Therapy (Investigational)
Therapeutic Category Targeted Therapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase)

‹ 1 … 24 25 26 27 28 ›

Product Range

Company

Global Network

Products

Vopratelimab

Utomilumab

Urelumab

INCAGN1876 (GITR)

MEDI1873 (GITR)

BMS-986156 (GITR)

Rilotumumab

Napabucasin

Simtuzumab

Devimistat

IACS-010759

Telaglenastat

Vopratelimab

Utomilumab

Urelumab

INCAGN1876 (GITR)

MEDI1873 (GITR)

BMS-986156 (GITR)

Rilotumumab

Napabucasin

Simtuzumab

Devimistat

IACS-010759

Telaglenastat